Moran Wealth Management LLC cut its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 44.6% during the third quarter, Holdings Channel reports. The institutional investor owned 1,402 shares of the semiconductor company’s stock after selling 1,130 shares during the period. Moran Wealth Management LLC’s holdings in Synopsys were worth $692,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in SNPS. Stanley Laman Group Ltd. lifted its stake in Synopsys by 542.9% during the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock worth $6,353,000 after purchasing an additional 10,874 shares during the last quarter. Symphony Financial Ltd. Co. lifted its position in shares of Synopsys by 4,780.9% during the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after buying an additional 39,395 shares during the last quarter. HBW Advisory Services LLC lifted its position in shares of Synopsys by 494.9% during the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock worth $1,851,000 after buying an additional 3,004 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Synopsys by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after buying an additional 4,815 shares in the last quarter. Finally, Westbourne Investments Inc. purchased a new position in shares of Synopsys in the 2nd quarter valued at $1,505,000. 85.47% of the stock is owned by institutional investors and hedge funds.
Synopsys Stock Performance
Shares of SNPS stock opened at $525.18 on Friday. The stock’s 50-day moving average price is $445.06 and its 200 day moving average price is $504.57. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $100.48 billion, a PE ratio of 65.73, a price-to-earnings-growth ratio of 4.37 and a beta of 1.12. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73.
Insider Buying and Selling at Synopsys
In other Synopsys news, insider Janet Lee sold 250 shares of the business’s stock in a transaction on Wednesday, January 7th. The shares were sold at an average price of $510.00, for a total value of $127,500.00. Following the transaction, the insider directly owned 12,209 shares of the company’s stock, valued at approximately $6,226,590. The trade was a 2.01% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.62% of the company’s stock.
Analysts Set New Price Targets
SNPS has been the subject of a number of research reports. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and reduced their price target for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Rosenblatt Securities raised Synopsys from a “neutral” rating to a “buy” rating and reduced their target price for the company from $605.00 to $560.00 in a report on Tuesday, December 9th. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Wells Fargo & Company lifted their price target on Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 11th. Finally, Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Eleven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $562.13.
Check Out Our Latest Stock Report on Synopsys
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
